Investorideas.com - #Cannabisstocks: MYM (CSE: MYM) (OTC: MYMMF) and the Sherbrooke Historical Society Partner to Create Concept for \'CannaCentre\' Museum at Cannabis Production Facility in Weedon, Quebec
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Friday, July 6, 2018
Investorideas.com - CSE New #Cannabis Listing - Tree of Knowledge International Corp. (TOKI); @CSE_News
Investorideas.com - CSE New #Cannabis Listing - Tree of Knowledge International Corp. (TOKI); @CSE_News
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; Part 2 with K. Lance Anderson of Dickinson Wright Discussing Cannabis IP in the U.S.
Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; Part 2 with K. Lance Anderson of Dickinson Wright Discussing
Cannabis IP in the U.S.
July 6th Potcast sponsored
by Lexaria Bioscience Corp. (CSE: $LXX.C) (OTC: $LXRP) and its new disruptive
drug delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC –July 6, 2018 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s
edition of its series, Investorideas.com
potcastsCM - cannabis news and stocks to watch plus insight from
thought leaders and experts.
Listen to today’s podcast, part 2:
Read this in full at http://www.investorideas.com/news/2018/cannabis/07069Potcasts-LanceAnderson.asp
Listen to previous podcast, part one:
http://www.investorideas.com/Audio/Podcasts/2018/070218-LanceAnderson.mp3
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast ;
looking at cannabis news, stocks to watch as well as insights from thought leaders
and experts. Today we will be finishing our two-part interview with K. Lance
Anderson of Dickinson Wright where we will discuss the cannabis market and the
laws surrounding it.
K. Lance Anderson has extensive experience preparing and negotiating technology
and intellectual property-focused transactions, as well as technology aspects
of mergers and acquisitions, joint ventures, and other complex commercial
transactions. A registered patent attorney, Mr. Anderson also conducts patent
prosecution, due diligence for licensing, and acquisitions, technology
agreements, strategic planning, patent prosecution, trade secrets, employment
mobility, and related operational legal issues.
Prior to private practice, Lance served for over ten years as in-house
counsel and lead intellectual property attorney for both a large public
research university system and an early stage venture capital company,
overseeing all facets of intellectual property development, management, and
transactions. His experience and background contribute to skill sets applicable
to technology transfer and emerging technology, high-tech, health-IT,
agricultural biotechnology, pharmaceuticals/life sciences, consumer products,
oil & gas, and renewable energy.
Lance represents clients within the innovation and research enterprise
including R&D, clinical and regulatory matters, strategic collaborations,
CRADA’s, manufacturing, distribution, engineering services, institutional
technology transfer, confidentiality and materials exchange, and related
alliances. In addition to representing clients on intellectual property issues,
he has been involved in many aspects of corporate law, operations, financing
and litigation ranging from start-up and early stage companies to mature market
leaders.
Dickinson Wright is positioned as one of the only full-service law firms
to welcome clients operating in this industry and to provide specialized
counsel both to clients operating with state-issued licenses and to businesses
providing goods and services to the industry.
In Part 2 of our interview with K. Lance Anderson we continue
discussing the state by state system in the US as well as the patent laws in
the cannabis market.
In regard to the
limitations or “glass ceiling” placed on the Cannabis market in the US with
expansion internationally and nationally, Anderson stated that “to have that
level of detail required for compliance, is always going to be a burden. I
think it will continue to hold back US companies that are operating in that
way.”
When asked about the
future of cannabis and what we might look forward to in the industry Anderson
went on to talk about the innovations in delivery methods. “Think about the
cannabis product as an edible. It is an oil, and it has to be metabolized by
the liver, called a first pass metabolism requirement and in essence it’s
poorly available. It’s not a very efficient process of orally administrating a
cannabis product. What you’re seeing are innovations to address that. Maybe
it’s more efficient uptake, which might mean higher bio-availability, or maybe
its stability. Maybe it’s the rapid onset of the desired effects. Those are
coming out. Someday you’re going to be able in 10 minutes to ingest something
orally and have the induced effects. On the other hand, there are antagonists
that out there. I think what we will see is the ability for a customer to
consume something for lunch and enjoy themselves and then be able to turn that
off. The ability to focus in on what I call designed delivery mechanisms to
meet everyday products and everyday users.”
We also discussed the
current state and future of patent laws regarding plant strains and breeder’s
rights. “You see the opportunity for breeder’s rights such as plant patents, to
be taken advantage of, but that doesn’t necessarily mean you won’t have access
to those innovative new lines. What it does mean is that there’s some
reasonable amount of protection from others asexually propagating that plant.
It may position these breeders to benefit for a while. But at the end of the
day can you protect the genetics of the cannabis plant from the context of
certain traits? There are various groups that want to make sure certain genomes
are sequenced and released and that will put a cushion between the innovators
and the protections they will be able to take advantage of. You will see people
take advantage of that, but I don’t think it will get to the level of the
soybean market being 90% controlled by Monsanto.”
In continuing to
discuss cannabis in comparison to agriculture and genetic modification and
plant patents. “Consumers aren’t going to accept genetically modified weed. It
just won’t happen. I think you will see it naturally balance with regard to
innovation and the protection of those innovations in contrast to people having
access to strains they want to have access to. With the extraction method and
the advent of distillate as a source material for processing oils for
vaporizers; the argument there is that it’s cleaner and that it doesn’t have
the impurities that a butane or CO2 based solvent would have. Those are selling
points. Those are well received by the industry.”
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on
Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
This Week's #CannabisStocks Added to Investor Ideas; (CSE: $MTEC.C, $KBEV.C) (OTCQB: $STMH)
This Week's #CannabisStocks
Added to Investor Ideas; (CSE: $MTEC.C, $KBEV.C) (OTCQB: $STMH)
Point Roberts, WA, Delta BC – July 6, 2018 –
Investorideas.com, a global news source and investor resource covering actively
traded sectors announces this week’s additions to its cannabis /hemp stock directory for investors
following the sector.
Investorideas.com tracks cannabis and hemp publicly
traded companies on the TSX, TSX.V, CSE, OTC, NYSE, NASDAQ, ASX and global stock exchanges and makes ongoing
additions to its stock directories for its members. Free previews of all
directories are available to the public with full login access only accessible
to members.
Read this news in full at http://www.investorideas.com/news/2018/cannabis/07062Stocks.asp
This week’s
cannabis companies include Stem Holdings Inc. (OTCQB: STMH), a leader in the U.S.
cannabis industry which builds state-of-the-art licensed solutions including
cultivation, processing and retail properties across multiple U.S. markets.
Also new are the CSE-Listed customer-centric tech company Cannvas MedTech Inc. (CSE:MTEC) and the cross-over
beverage company Koios Beverage
Corp. (CSE: KBEV) (OTC: SNOVF), whose subsidiary Cannavated Beverage Co., just announced
it entered into an exclusive licensing agreement with CanCore Concepts Ltd
(www.keefbrands.com) for a line of cannabis-infused beverages.
Investorideas.com
cannabis/marijuana and hemp news and investing content now includes our daily potcastsCM ; podcasts featuring cannabis news and stocks to watch plus
insight from thought leaders and experts. Recent
interviews include Montel Williams, The Arcview Group, Electrum Partners and
the CEO of Cronos Group Inc. (NASDAQ: CRON).
The cannabis stocks potcast (podcast)
is also released with an accompanying written transcript. Learn more and sign up at http://www.investorideas.com/Audio/Potcasts.aspOr www.potcasts.ca
To sponsor our daily podcast for the month or to be an expert guest
please contact us!
Cannvas MedTech Inc. (CSE:MTEC) is a leading
business technology company within the cannabis space. The company designs and
builds customer-centric solutions that enable its partners to harness the power
of data to truly understand their customers, industry, and key business
drivers.
Stem Holdings Inc. (OTCQB: STMH) has positioned
itself as a leader in the U.S. cannabis industry by building state-of-the-art
licensed solutions to include: cultivation, processing and retail properties
across multiple U.S. markets. As an innovative real estate company, Stem
Holdings acquires and improves properties for the cannabis industry. Because
traditional institutional lenders have not directly participated in the
financing of marijuana-related real estate, there has been a shortage of
available improvement capital. Stem Holdings has set itself apart by building
and partnering with a variety of marijuana-based businesses, from edibles to
hemp cultivation. The Company has developed an extensive portfolio of
award-winning consumer-facing brands, partnering with well known, branded
cannabis operators with a proven track record of success, such as TJ's Gardens,
Cannavore, Incredibles, Doseology and Green T-Farms.
Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) through its wholly-owned subsidiary
Koios, Inc., is an emerging functional beverage company which has an available
distribution network of more than 2,000 retail locations across the United
States in which to sell its products. Koios has relationships with some of the
largest and most reputable distributors in the United States, including Europa
Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Together these distributors
represent more than 80,000 bricks and mortar locations across the United States
- from sports nutrition stores to large natural grocery chains including Whole
Foods and Sunflower markets. Through its partnership with Wishing-U-Well, Koios
also enjoys a large presence online, including being an Amazon choice
product. Koios uses a proprietary blend
of nootropics and natural organic compounds to enhance human productivity
without using harmful chemicals or stimulants. Koios products can enhance
focus, concentration, mental capacity, memory retention, cognitive function,
alertness, brain capacity and create all day mental clarity. Its ingredients
are specifically designed to target brain function by increasing blood flow,
oxygen levels and neural connections in the brain. Koios is one of the only drinks in the world
to infuse its products with MCT oil. MCT oil is derived from coconuts and has
been shown to help the body burn fat more effectively, create lasting energy
from a natural food source, produce ketones in the brain, allowing for greater
brain function and clarity, support healthy hormone production and improve
immunity. Cannabis: June 2018 - Cannavated Beverage Co., a wholly-owned
subsidiary of Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF), is pleased to
announce it has entered into an exclusive licensing agreement with CanCore
Concepts Ltd (www.keefbrands.com) for a line of cannabis-infused beverages.
The complete marijuana/hemp stock list available for purchase in a PDF
format:
Investorideas.com global stock directories are part
of the membership program on the site, accessed either by login and password or
available in PDF format. The directories include stocks trading on the
TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving
retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About
Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global
investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.
Cannabis
content also includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and
stock directory pages, a cannabis investor group on Linkedin.com, the 420
Cannabis Investor ideas directory www.420cannabisinvestorideas.com, and Global Cannabis
Investing at www.Globalcannabisinvesting.com.
Learn more about our Services for Publicly traded and private companies:
http://www.investorideas.com/Investors/Services.asp
Investorideas is also listed on The Canadian Securities Exchange
(CSE) Directory of Service Providers –Learn more about us
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution,social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
Contact Investorideas.com
800-665-0411
#CannabisStocks to Watch Following Recent Passage of Bill C-45; (TSX: $APH.TO, USOTC: $APHQF), (CSE: $EVA.C, OTCQB: $AXHLF), (TSX: $WEED.TO, NYSE: $CGC), (TSX: $TRST.TO)
#CannabisStocks
to Watch Following Recent Passage of Bill C-45; (TSX: $APH.TO, USOTC: $APHQF),
(CSE: $EVA.C, OTCQB: $AXHLF), (TSX: $WEED.TO, NYSE: $CGC), (TSX: $TRST.TO)
Point
Roberts, WA and Delta, BC – July 6, 2018 (Investorideas.com Newswire) Cannabis
Stocks to watch alert - Investorideas.com, a global news source and
investor resource covering cannabis stocks issues a sector news alert on
Canadian cannabis stocks following the Senate's recent passing of Bill C-45 to
federally legalize cannabis.
Receiving
royal assent, the bill is now officially law and sales are expected to begin
mid-October. Industry analysts are now releasing new data and trying to predict
what this new era of legalized cannabis will add to the economy.
Read
this in full at http://www.investorideas.com/news/2018/cannabis/07061Stocks.asp
In
a recent Deloitte report, A society in
transition, an industry ready to bloom, ";Canadians are expected
to spend as much as $7.17 billion on cannabis products in 2019 and increase
their overall consumption by up to 35 per cent once recreational cannabis is
legalized later this year, according to a new report by Deloitte. Legal
recreational cannabis sales could generate up to $4.34 billion in sales,
accounting for more than half of total cannabis sales, but the illegal market
could still be worth more than $1 billion a year."
“Uruguay and Canada are leading the way on
adult-use legalization, and Germany broke barriers in 2017 on medical-use
availability. This means worldwide spending on legal cannabis should hit $32
billion by 2022,” said Tom Adams, Editor-in-Chief at Arcview Market Research
and Managing Director of BDS Analytics’ Industry Intelligence Division.
As industry and investors gear up for a brave new
world of cannabis in Canada, several companies weighed in on the historic event
and followed up with news demonstrating the momentum the sector is witnessing.
EVITRADE Health Systems Corp. (CSE:EVA) (OTCQB:AXHLF) issued commentary on June 20, 2018 saying,“The Senate overwhelmingly voted in
favour of the revised bill from the House of Commons which should create a
fully federally legal cannabis program for Canada within eight to twelve weeks.
This vote will provide a framework from which companies like ours can utilize
advanced scientific research and developments to operate successfully within
the cannabis market in Canada.”
Two days later EVITRADE Health Systems Corp. issued
follow- up news reporting they had signed a Letter of Intent to collaborate
with West Coast Medical Solutions Ltd. (WCMS). “WCMS together with their
partner Ecovita Packaging Ltd. intend to undertake a project to apply to become
a Licensed Dealer (LD) as issued by Health Canada for Class A precursors. The
Company will focus on uses regarding medical cannabis, THC and cannabidiol
(CBD). Ecovita maintains a relationship with Medtrica Canada which is privately
owned by one of the shareholders of WCMS. Medtrica holds a FDA and Health
Canada MDEL (Medical Device Establishment License) and is an ISO13485 medical
products manufacturer in British Columbia, Canada. Medtrica is also currently
building a brand new 40,000 sq. ft. state of the art manufacturing, processing,
and packaging facility with an estimated completion date in October 2018.”
“This latest agreement provides the manufacturing
capabilities and access to a fully accredited ISO13485 medical device
manufacturing facility; which will greatly strengthen our overall biotech
capabilities and provide a level of integration that will make us more
competitive and efficient." to become a certified Licensed Dealer, we will
be able to further our plans to develop and distribute medical grade products
that can potentially solve a series of ailments that plague the human
condition," said CK Cheung, CEO of Evitrade."
A well-known name on the playing field also issued
a statement following the passage of Bill C-45.
Vic Neufeld, CEO of Aphria (TSX: APH and USOTC: APHQF) said, "Today's passage of Bill C-45 through
the Senate is a historic milestone towards safe and legal recreational cannabis
in Canada. We applaud the government's drive to establish a rational regulatory
framework for adult-use cannabis that is designed to protect public health and
safety, restrict access to youth, and eliminate the black market. It is a
significant day that further cements Canada as the preeminent leader in the
global cannabis sector."
On June 29th Aphria announced that it
has signed a Supply Agreement with the Manitoba Liquor and Lotteries
Corporation to provide a portfolio of high-quality, branded cannabis and
cannabis derivative products for sale in Manitoba's adult-use market.
“Under the terms of the Agreement, the Company will
supply up to 2.7 million grams of cannabis and cannabis derivative products in
the first year of the agreement, including both Ontario and BC dried flower,
pre-rolls and cannabis oils. The wide range of products will be available for
sale at licensed retailers across the province. It is anticipated that
additional products currently being developed by Aphria, such as vapes and
edibles, will also be made available in Manitoba when authorized for sale under
the Cannabis Act.”
Recognized leader and first NYSE listed cannabis
stock, Canopy Growth Corporation (TSX: WEED) (NYSE:CGC) said,”We welcome the recently announced Cannabis
Regulations in support of the Cannabis Act, one of the final steps in the
progression towards a national system for the regulated production, sale and
consumption of quality-controlled cannabis in Canada.”
“The regulations, upon an initial review, present
an exhaustive and sophisticated system for production and marketing, and are
in-line with the Company's expectations. They represent the culmination of
years of experience gained through the medical cannabis system, and will serve
Canadian patients, adult-use consumers, producers and stakeholders well as the
country approaches the end of cannabis prohibition.”
Canopy announced on June 29th they also
had completed an agreement with the Manitoba Liquor and Lotteries Corporation
to supply the province with high quality cannabis products.
“Under the terms of the agreement, Canopy Growth
will supply the Manitoba market with up to 6,500 kilograms of cannabis products
over the next twelve months to meet demand from the adult use recreational
cannabis market set to open on October 17, 2018.”
Commenting on the royal ascent, CannTrust Holdings
Inc. (TSX: TRST) released news saying, “CannTrust is applauding
the granting of Royal Assent to Bill C-45, the Cannabis Act. With Royal Assent
received, the legislation legalizing cannabis for adult consumer use has now
passed its final official step, and retail sales are to commence on October 17,
2018, as announced by Canada's federal government.“
"While the federal government has recently
announced the commencement date for adult consumer use, CannTrust has been
working towards this date for a very long time. We are well positioned for this
rapid growth with our new product offerings, infrastructure, research and
development and staffing. At the same time we continue to lead the medical
industry through our customer support, innovative portfolio and most of all,
our trusted standardized products. Initial adult consumer use order discussions
with the Provinces have exceeded our preliminary estimates reflecting the
market's confidence in our abilities and the understanding of our consistent quality.
This truly is an exciting and momentous time for both our Company and our
nation", says Brad Rogers, President of CannTrust.
CannTrust is initially launching three recreational
brands of Cannabis in Canada – liiv, SYNR.G and Xscape. This trio of brands
will address the needs of three distinct target audiences: the knowledgeable
enthusiast, the social consumer and the experience seeker. Each of the brands
will include a set of carefully curated strains and the products will be
available in a variety of formats including dried flower, pre-rolls, oils and
capsules.
Sources –
Arcview
About
Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global
investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.
Investorideas.com cannabis/marijuana and hemp news
and investing content includes potcastsCM – podcasts featuring cannabis news and stocks to watch plus
insight from thought leaders and experts. Cannabis content also includes
http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a
cannabis investor group on Linkedin.com, the 420 Cannabis Investor ideas
directory www.420cannabisinvestorideas.com, and Global
Cannabis Investing at www.Globalcannabisinvesting.com.
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution,social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country. Disclosure : Investorideas was compensated for
this tag article to include EVITRADE Health Systems Corp.- learn more about
costs and services http://www.investorideas.com/News-Upload/
Contact Investorideas.com
800-665-0411
Thursday, July 5, 2018
Investorideas.com - #Cannabisstocks: Canopy Growth (TSX: $WEED.TO), (NYSE: $CGC) Calls New Brunswick Home - Company Plans to Create 136 High Quality Local Jobs
Investorideas.com - #Cannabisstocks: Canopy Growth (TSX: $WEED.TO), (NYSE: $CGC) Calls New Brunswick Home - Company Plans to Create 136 High Quality Local Jobs
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Subscribe to:
Posts (Atom)